|
|
|
An antiviral molecule called a 'tetherin' that acts to inhibit HIV-1 particle release from cells is identified in a paper published online in Nature. The protein CD317 is involved in tethering HIV particles to the cell surface, and stopping the release of the virus.
The HIV protein Vpu is required for the release of viral particles, and evidence for a tetherin molecule has accumulated over the last few years. Paul Bieniasz and colleagues show that Vpu works to neutralize the host cell protein CD317, which they rename tetherin. In this way it allows efficient discharge of HIV-1 particles from infected cells. The team argue that inhibition of virus release by tetherin is a previously unknown mechanism by which organisms protect themselves against certain viruses. CONTACT Paul Bieniasz (Rockefeller University, New York, NY, USA)
E-mail: pbienias@adarc.org Abstract available online. (C) Nature press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|